InvestorsHub Logo
Followers 67
Posts 1293
Boards Moderated 0
Alias Born 08/12/2014

Re: monentum2play post# 557561

Saturday, 01/07/2023 6:17:07 PM

Saturday, January 07, 2023 6:17:07 PM

Post# of 700280
You may be right the major cable channels won't touch a stock on the OTC, but the channels can of course report on major medical and biotech breaking news. They can and should report major advances in clinical trials and potential new treatments which have the potentials to save lives regardless what company which hold the news!

It's just a matter of who can do that job, contacting and persuading the media if they don't report the news, they are missing out a major breaking news.

That means they may not have interests or may be prohibit to reporting an OTC company but they should be able to report substance news. It will be no taboo for them to report the results of the Phase 3 clinical trial using DCVax-L (Murcidencel) vaccine to treat GBM patients.

The problem is does Northwest Bio have the right advocating firm/person to do that kind of job? From the history, Northwest Bio seems to have never had that kind of record. Can this time be different with the positive news and JAMA publication?

Personally, I think it is coming!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News